- China’s brain-computer interface industry is scaling rapidly from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.1
- NeuroXess is advancing to human trials with a mix of government backing and investor enthusiasm, positioning to compete with Neuralink.2
- China’s BCI industry is being framed as racing ahead of or challenging U.S. dominance in clinical trials and technology.1
- Policy and regulatory fast-tracking are supporting the domestic BCI industry.1
- Elon Musk’s Neuralink has been cited as a catalyst for increased Chinese BCI investment and competitive urgency.1
Gardner updates
- China reports more than 50 human BCI implants and real-time decoding of Chinese speech.1
- Implementation evidence is reported claims, not peer-reviewed.1
Footnotes
-
https://techcrunch.com/2026/02/22/chinas-brain-computer-interface-industry-is-racing-ahead/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
https://news.google.com/rss/articles/CBMi1wJBVV95cUxPaTQtSUhwd28tY1dJNlJ2d1ItaC1NTTRyNmpMM1BNYm9PZ0h5TDZUeFJGNlQ5NERoU0dhRktobWZZYjRzblBVSThsUUNoYkpqOHNVOXZKbnRFd2NSZ1BDOElPY2ZOZ2QzN0tzRHd1TC1QOENpcDI0Z1N2Tmlya2dNa3RjOUFuYnpaR2hsVi1FdUtONEJkejdYTEpoUm1SUDhlTU1sYnIzWngwSEs0ckFpWmkyQ2ZxM1RiQjdCMnRuMXp1UExKZWZSbjlWbGlXd1oxenBDWlJvUnF3MjN4YmdNZ0FjekZVWElBZGpLWFg3WUlZZjNRdHJpSUNRRE5SMWFVQ0NUUkpZd0tkOUxicmlITFFYdmg4QXQ0STVLZDhBbjY3MUc3TDdmLU9vbEtGcmxvVUNBdkNvcC1BNmxwQUc3Mmk3eDVZT3BhNzV1RThQaVQ3OXpOV2Fn?oc=5 ↩